Search

Search Constraints

You searched for: Author/Creator Moriano, Clara

Search Results

1. AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS. (June 2019)

2. AB0721 EPIDEMIOLOGICAL, CLINICAL AND PROGRESSION FACTORS OF SPONDYLOARTHRITIS IN A TERTIARY CARE HOSPITAL. (June 2019)

3. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review. (15th February 2022)

4. FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS. (June 2019)

5. FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET'S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE. (June 2019)

6. FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS. (June 2019)

7. FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB. (June 2019)

8. OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS. (June 2019)

9. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?. (5th May 2021)

10. SAT0215 APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHÇET'S DISEASE. MULTICENTER STUDY OF 49 CASES IN CLINICAL PRACTICE. (June 2019)